Document mpyy8MBKXevKZz5m7EE3En2vJ

DownloadSearchable PDFRandom document
To: Clegg, Patsy M SCC-CHSE-PC <patsy.clegg@shell.com>; Hulse, Michael SCC- CHSEMH <michael.hulse@shell.com>; Tsai, Shan P SHLOIL-SHS <Shan.Tsai@shell.com> From: Cagen, Stuart Z SCC-CF-SS </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=SC724012> Cc: Bcc: Received Date: 2005-04-2020:12:23 GMT Subject: FW: BHRC-TC... FYI: TSCA 8e sent by XOM Re: BIMDS manuscript Stuart Cagen Shell Chemical LP One Shell Plaza, 91 0 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 1407 Fax: 3325 Other Tel: +1 8326463987 Email: stuart.cagen@shell.com Internet: http://www.shell.com/chemicals "Business Success through HSSE Excellence" -----Original Message----From: Bruce Jarnot [mailto:jarnotb@api.org] Sent: Wednesday, April 20,20052:49 PM To: benzconsort-tc@ listserve. api. org Cc: michael.g.bird@exxonmobil.com; benzconsort-oc@listserve.api.org; Richard Irons (E-mail); Fu Hua (Email); Otto Wong (E-mail); Tom Armstrong (E-mail); Rob Schnatter (E-mail); Yimei Zhou (E-mail) Subject: BHRC-TC... FYI: TSCA 8e sent by XOM Re: BIMDS manuscript Importance: High Benzene Health Research Consortium (BHRC) Technical Committee, and colleagues - FYI ... ExxonMobil filed a TSCA 8(e) submission to USEPA on health findings reported in the draft publication by Irons et aI., on Benzene-Induced Myelodysplastic Syndrome (BIMDS) seen in a cohort of Shanghai workers. The attached zip file contains: -- a copy of ExxonMobil's TSCA 8(e) letter (1-page pdf); -- a summary of the manuscript (1-page doc); and -- a full-text copy of the draft publication (19-page pdf). The draft manuscript is also available on the Shanghai Health Study (SHS) web site. Best Regards - Bruce. > -----Original Message----From: michael.g.bird@exxonmobil.com [ mailto:michael.g.bird@exxonmobil.com] Sent: Monday, April 18, 2005 5: 19 PM SH ELL-MCCLU RG-064570 To: Bruce Jarnot Cc: rick. p. brown@exxonmobil.com; dennis.j. devlin@exxonmobil.com; brian.e.doll@exxonmobil.com; stephen.m.bowes@exxonmobil.com; glenna.m.kyle@exxonmobil.com; Iynn.b.russo@exxonmobil.com Subject: TSCA 8e letter re BIMDS Bruce, ExxonMobil has submitted under TSCA 8(e) a summary of the draft publication of Irons et al relating to BIDMS which I had previously forwarded to you. The letter to the EPA is attached below and as indicated by Stephen Bowes should be shared with the SHS consortium and investigators. We would appreciate it if you could distribute this to the SHS committees! members and to the investigators. Thank you Michael Michael G. Bird, PhD., DABT Toxicology & Environmental Sciences Division, ExxonMobil Biomedical Sciences, Inc. 1545 Route 22 East P.O. Box 971 Annandale, New Jersey 08801-0971 tel: 9087301060 fax: 908 730 1199 Email: michael.g.bird@exxonmmobil.com ----- Forwarded by Michael G Bird/East-US/ExxonMobil on 04/18/05 05:05 PM Stephen M Bowes To: Michael G Bird/East-US/ExxonMobil@xom cc: Brian E Doll/FairfaxiMobil-Notes@xom, Lynn B 04118/05 03:43 PM Kyle/HoustonlExxonMobil@xom, Russo/FairfaxlExxonMobil@xom, Glenna M Michael S McWiliiams!FairfaxlExxonMobil@xom Subject: BIMDS letter to Agency Michael, Attached is the letter sent by ExxonMobil to EPA under TSCA 8(e) on the BIMDS information. This information should be shared within the consortium and with the investigators. (See attached file: 8e on BIMDS April 2005.pdf) Regards, Stephen Bowes, Ph.D. Sr. Health & Product Stewardship Associate ExxonMobil Biomedical Sciences, Inc. Tel: (703) 846-1199.... Fax: (703) 846-5571 .... Pager (732) 437-0999 > SHELL-MCCLURG-064571 Attachments: BIMDS Docs 04 2005.zip SH ELL-MCCLU RG-064S72